16.07.2026
Illicit Medicines In South Africa Spark Sahpra Crackdown
Illicit medicines in South Africa are rising, prompting Sahpra to launch a national campaign on counterfeit drugs and unsafe online sellers.
16.07.2026
10.11.2026
The FDA orders GLP-1 eye risk warnings for diabetes and weight-loss medicines after reviewing NAION evidence. Read what the changes mean for care.
08.11.2026
The Xtandi patent dispute reaches South Africa’s Constitutional Court on 23 November. Read what is at stake for generic access and damages claims.
06.11.2026
Pharmaceutical sovereignty is back in focus as Ebola spreads in the DRC. See how pooled procurement and shared regulation could secure supplies.